Why have this procedure done in China specifically?

China offers this advanced therapy at approximately $150,000, significantly lower than in the U.S. or Europe, where costs can exceed $500,000. Chinese hospitals have high patient volumes, providing extensive experience in managing CAR-T complications like CRS. Many centers are JCI-accredited and use internationally sourced reagents and manufacturing standards. Additionally, streamlined regulatory approval allows access to commercial BCMA CAR-T products, and medical-tourism coordinators assist with travel, translation, and follow-up care.